GC Chemie Pharmie Ltd. (GCCPL), one of India’s trailblazers in the pharmaceutical and nutraceutical sectors, commemorates 44 years of transformative leadership under its founder and Chairman, Gautam Shah. Established in 1981, the company has evolved from a modest API trading firm into a global healthcare powerhouse with a presence in over 30 countries.

A pivotal moment in GCCPL’s history came in 2009–10 with the acquisition of Eagle Chemical Works, enabling in-house API manufacturing. That same year, the company entered the vaccine space with the launch of its first preventive health product, marking a significant diversification of its portfolio. In 2010–11, GCCPL furthered its mission of affordable care through the rollout of its P2P (Product to Patient) division.